DE69940058D1 - Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin - Google Patents

Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin

Info

Publication number
DE69940058D1
DE69940058D1 DE69940058T DE69940058T DE69940058D1 DE 69940058 D1 DE69940058 D1 DE 69940058D1 DE 69940058 T DE69940058 T DE 69940058T DE 69940058 T DE69940058 T DE 69940058T DE 69940058 D1 DE69940058 D1 DE 69940058D1
Authority
DE
Germany
Prior art keywords
von willebrand
willebrand factor
binding
glycoprotein
glycokallidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69940058T
Other languages
English (en)
Inventor
Naoyuki Fukuchi
Fumie Futaki
Morikazu Kito
Seiichi Sato
Takayuki Kajiura
Yukitsugu Ono
Koichi Ishii
Akiko Tanaka
Junko Shinozaki
Yasuko Jojima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Application granted granted Critical
Publication of DE69940058D1 publication Critical patent/DE69940058D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G01N2333/755—Factors VIII, e.g. factor VIII C [AHF], factor VIII Ag [VWF]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DE69940058T 1998-04-23 1999-01-13 Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin Expired - Lifetime DE69940058D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11396298 1998-04-23
PCT/JP1999/000089 WO1999054360A1 (fr) 1998-04-23 1999-01-13 Substance possedant une activite antithrombotique et procede de detection de glycokallidine

Publications (1)

Publication Number Publication Date
DE69940058D1 true DE69940058D1 (de) 2009-01-22

Family

ID=14625575

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69940058T Expired - Lifetime DE69940058D1 (de) 1998-04-23 1999-01-13 Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin

Country Status (6)

Country Link
US (3) US6878811B1 (de)
EP (1) EP1074564B1 (de)
JP (2) JP4380067B2 (de)
AT (1) ATE417068T1 (de)
DE (1) DE69940058D1 (de)
WO (1) WO1999054360A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4380067B2 (ja) * 1998-04-23 2009-12-09 味の素株式会社 抗血栓活性物質及びグリコカリシンの検出法
AR035779A1 (es) 2001-02-06 2004-07-14 Genetics Inst Llc Polipeptidos de fusion derivados de glicoproteina ib alfa de plaqueta y metodos de uso de los mismos
US7235558B2 (en) 2002-06-06 2007-06-26 Sanofi-Aventis Deutschland Gmbh Inhibitors of the GPIb—vWF interaction, their preparation and use
CA2530972A1 (en) 2003-06-11 2004-12-23 Wyeth Platelet glycoprotein ib alpha variant fusion polypeptides and methods of use thereof
EP1642128B1 (de) 2003-07-07 2016-11-16 University Of North Carolina At Chapel Hill Verfahren und system zum nachweis von von-willebrand-faktor (vwf)-multimeren
JP2005073528A (ja) * 2003-08-28 2005-03-24 Genetics Inst Llc 生物学的系における生物学的組織への血球の接着を阻害する方法、ならびにその方法に使用するための組成物
CN101176000A (zh) * 2005-04-22 2008-05-07 惠氏公司 用于测定糖蛋白Ibα(GPIBα)蛋白质的方法
WO2010111414A1 (en) * 2009-03-24 2010-09-30 Bayer Healthcare Llc Factor viii variants and methods of use
EP2431739A1 (de) * 2010-09-21 2012-03-21 Sanofi Verfahren zur Erkennung und/oder Quantifizierung der Interaktion von Plättchen mit Interaktionspartnern
EP2637024A1 (de) * 2012-03-05 2013-09-11 Siemens Healthcare Diagnostics Products GmbH Screeningverfahren zum Auffinden von Proben mit einer Störung der Funktionalität der GPIb-Von Willebrand Faktor-Interaktion
KR20210134990A (ko) * 2018-02-20 2021-11-11 그리폴스 다이어그노스틱 솔루션즈 인크. 재조합 ＧｐＩｂα 수용체 단백질을 포함하는 조성물

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US5340727A (en) * 1987-11-17 1994-08-23 The Scripps Research Institute GPIbα fragments and recombinant DNA expression vectors
US5321127A (en) * 1991-03-18 1994-06-14 Brigham And Women's Hospital Antiplatelet and antithrombotic activity of platelet glycoprotein Ib receptor fragments
AU3734793A (en) * 1992-02-26 1993-09-13 Scripps Research Institute, The Mutant gpibalpha fragments and recombinant expression thereof
US5585243A (en) * 1993-09-15 1996-12-17 The Blood Center Of Southeastern Wisconsin, Inc. Method of detecting cytopenia that is mediated by drug-dependent antibody binding to blood cells
EP0741142A4 (de) * 1993-09-28 1998-10-21 Ajinomoto Kk Peptid und antithrombotisches mittel
JPH07330797A (ja) * 1994-05-31 1995-12-19 Sumitomo Metal Ind Ltd 新規細胞接着活性ペプチド
EP0793504B1 (de) 1994-12-12 2005-06-08 Beth Israel Deaconess Medical Center, Inc. Chimäre zytokine und ihre verwendung
JPH08333400A (ja) 1995-06-09 1996-12-17 Ajinomoto Co Inc 抗血栓活性を有する融合蛋白質及びその製法
SE504496C2 (sv) * 1995-07-03 1997-02-24 Stromsholmens Mek Verkstad Anordning vid en gasfjäder för avstrykning av en kolvstång
US6369027B1 (en) 1995-12-22 2002-04-09 Amgen Inc. Osteoprotegerin
CN1154726C (zh) 1995-12-27 2004-06-23 基因技术股份有限公司 具长半衰期的ob蛋白质衍生物
JP4380067B2 (ja) * 1998-04-23 2009-12-09 味の素株式会社 抗血栓活性物質及びグリコカリシンの検出法
US6790823B1 (en) * 1998-04-23 2004-09-14 Amgen Inc. Compositions and methods for the prevention and treatment of cardiovascular diseases

Also Published As

Publication number Publication date
US6878811B1 (en) 2005-04-12
WO1999054360A1 (fr) 1999-10-28
ATE417068T1 (de) 2008-12-15
WO1999054360A8 (fr) 1999-12-29
US20100120172A1 (en) 2010-05-13
US7608695B2 (en) 2009-10-27
EP1074564A4 (de) 2004-10-27
JP2008224684A (ja) 2008-09-25
EP1074564A1 (de) 2001-02-07
JP4380067B2 (ja) 2009-12-09
EP1074564B1 (de) 2008-12-10
US20040229288A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
DE69940058D1 (de) Stoff mit antithrombotischer aktivität und verfahren zur bestimmung von glycokallidin
DK38892D0 (da) Proteinpraeparat, monoklonalt antistof fremstillet dermed, fremgangsmaade og middel til detektering, dna-sekvens og extrachromosomalt element indeholdende en saadan dna-sekvens
DE3786200T2 (de) Diagnostische Verfahren zum Nachweis von Lymphomen bei Menschen.
DE69429192D1 (de) Ein verfahren zur bestimmung von kollagenfragmenten in körperflüssigkeiten, ein testkit und mittel zur durchführung des verfahrens, und seine verwendung zur feststellung von mit dem kollagenmetabolismus assoziierten störungen
DE69840669D1 (de) Pca3, pca3-gene und verfahren zu ihrer verwendung
ATA209883A (de) Verfahren zur fluorimetrischen bestimmung der konzentration von in einer substanz enthaltenen stoffen und anordnung zur durchfuehrung dieses verfahrens
DE3671298D1 (de) Verfahren zur konzentrationsbestimmung einer komponente in gasen und elektrochemische einrichtung, geeignet zur durchfuehrung des verfahrens.
DE3485299D1 (de) Nachweis von antigen aktiven aminosaeurensequenzen.
NO864872D0 (no) Paavisning av aktiverte blodplater med antistoffer mot celleoverflateantigener.
DE3779706D1 (de) Enzymsensor zur bestimmung von glutaminat-konzentration.
ATE138739T1 (de) Durch den liganden vermitteltes immunofunktionelles verfahren zur bestimmung hormonbindender proteine
ATA718079A (de) Verfahren zur direkten bestimmung von eisen im blutserum und reagens zur durchfuehrung des verfahrens
DE59107797D1 (de) Verfahren zum Nachweis von phosphoryliertes Tyrosin enthaltenden Proteinen
DE59500133D1 (de) Verfahren zur Erkennung von seitenverkehrt angeschlossenen Lambda-Sonden
AT360661B (de) Verfahren zur bestimmung von prothrombin und reagens zur durchfuehrung des verfahrens
DE69840895D1 (de) Monospezifische antikörper gegen fibrinogen und fibrinopeptide b
DE69731845D1 (de) Verfahren zum nachweis von protein s
DE59101035D1 (de) Verfahren zur bestimmung von gaskonzentrationen und gassensor mit festem elektrolyten.
ATE153770T1 (de) Künstliche standard- und kontrollseren zur verwendung in verfahren zur bestimmung von antikörpern
ATE142224T1 (de) Peptide von sm-d-antigen, deren benützung zum nachweis von disseminierten lupus-erythemateux
Lavergne et al. Isolation of human antibodies to factor VIII
DE59914992D1 (de) Methode zur zellulären high-throughput-detektion von nukleären rezeptor-liganden-interaktionen
ATE94994T1 (de) Verfahren und reagenz zur bestimmung von eisen.
Perret et al. Silver staining of high molecular weight proteins on large-pore polyacrylamide gels
ATE191565T1 (de) Verfahren zum nachweisen von antikörpern und antigenen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition